The Board of Repco Home Finance at its meeting held on 11 November 2022 has approved the appointment of RVaithianathan DIN 05267804 and Usha Ravi DIN 09788209 as Additional Directors in the category of a Non-Executive Independent Director of the Company for a period of 4 consecutive years from 11 November 2022 upto 10 November 2026 subject to the approval of the Shareholders
Amrapali Industries has revised the meeting of the Board of Directors which was scheduled to be held on 12 November 2022 The meeting will now be held on 14 November 2022
The Board of Kovai Medical Center Hospital at its meeting held on 11 November 2022 has appointed P K Gopikrishnan as CFO of the company He will replace M K Ravindra Kumar who resigned from the post on 03 October 2022
Suprajit Engineering has received affirmation in credit ratings from CRISIL as under Long term rating – CRISIL AA Stable Short term rating – CRISIL A1
Natco Pharma announced that Bristol Myers Squibb Teva and Natco have been named defendants in an antitrust lawsuit in the US by Walgreens Co regarding Lenalidomide Revlimid Natco believes this matter is without merit Teva is the ANDA holder and front-end marketing partner for the generic product in the US
NILE announced that the Board of Directors of the Company at its meeting held on 11 November 2022 inter alia have recommended the interim dividend of Rs 2 per equity Share ie 20Percentage subject to the approval of the shareholders
Velox Industries has revised the meeting of the Board of Directors which was scheduled to be held on 12 November 2022 The meeting will now be held on 14 November 2022
Sun Retail has postponed the meeting of the Board of Directors which was scheduled to be held on 12 November 2022 The meeting will now be held on 14 November 2022
Poojawestern Metaliks will hold a meeting of the Board of Directors of the Company on 17 November 2022
The Board of HEG at its meeting held on 11 November 2022 has approved entering into Manufacturing of Graphite Anodes for lithium ion cells and its allied and ancillary products business through incorporation of a subsidiary company
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
